Literature DB >> 12749723

Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States).

Phyllis A Wingo1, Patricia M Jamison, Robert A Hiatt, Hannah K Weir, Paul M Gargiullo, Mary Hutton, Nancy C Lee, H Irene Hall.   

Abstract

OBJECTIVE: In preparation for jointly publishing official government cancer statistics, the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI) compared incidence rates from NCI's Surveillance Epidemiology and End Results (SEER) Program and CDC's National Program of Cancer Registries (NPCR).
METHODS: Data for 1999 covering 78% of the US population were obtained from SEER and selected NPCR registries that met high quality data criteria. Incidence rates (per 100,000 population) were age-adjusted to the 2000 US standard population, and 95% gamma confidence intervals were estimated.
RESULTS: NPCR rates for all sites combined were higher than SEER rates (males: NPCR 553.6, SEER 538.7; females: NPCR 420.8, SEER 412.5), but rates for specific cancer sites varied by registry program. Rates for colon cancer (males: NPCR 47.0, SEER 42.7; females: NPCR 36.5, SEER 33.8) and tobacco-related cancers were higher in NPCR than SEER. In contrast, NPCR rates were lower than SEER rates for cancers of the female breast (NPCR 134.0, SEER 135.9), prostate (NPCR 162.0, SEER 170.2), and melanoma as well as for cancers more common among Asians and Pacific Islanders (e.g., stomach cancer).
CONCLUSIONS: Rate differences may arise from population differences in socio-demographic characteristics, screening use, health behaviors, exposure to cancer causing agents or registry operations factors.

Entities:  

Mesh:

Year:  2003        PMID: 12749723     DOI: 10.1023/a:1023002322935

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  63 in total

1.  The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.

Authors:  Christoph Jakob Ackermann; Ulrich Guller; Wolfram Jochum; Bruno M Schmied; Rene Warschkow
Journal:  Int J Colorectal Dis       Date:  2018-06-07       Impact factor: 2.571

2.  The past, present, and future of cancer incidence in the United States: 1975 through 2020.

Authors:  Hannah K Weir; Trevor D Thompson; Ashwini Soman; Bjørn Møller; Steven Leadbetter
Journal:  Cancer       Date:  2015-02-03       Impact factor: 6.860

3.  Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006.

Authors:  Hannah K Weir; Loraine D Marrett; Vilma Cokkinides; Jill Barnholtz-Sloan; Pragna Patel; Eric Tai; Ahmedin Jemal; Jun Li; Julian Kim; Donatus U Ekwueme
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

4.  Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South Carolina.

Authors:  Alex van der Steen; Amy B Knudsen; Frank van Hees; Gailya P Walter; Franklin G Berger; Virginie G Daguise; Karen M Kuntz; Ann G Zauber; Marjolein van Ballegooijen; Iris Lansdorp-Vogelaar
Journal:  Health Serv Res       Date:  2014-10-16       Impact factor: 3.402

5.  Patients with Adenocarcinoma of the Small Intestine with 9 or More Regional Lymph Nodes Retrieved Have a Higher Rate of Positive Lymph Nodes and Improved Survival.

Authors:  Alexander Wilhelm; Sascha A Müller; Thomas Steffen; Bruno M Schmied; Ulrich Beutner; Rene Warschkow
Journal:  J Gastrointest Surg       Date:  2016-02       Impact factor: 3.452

6.  The history and use of cancer registry data by public health cancer control programs in the United States.

Authors:  Mary C White; Frances Babcock; Nikki S Hayes; Angela B Mariotto; Faye L Wong; Betsy A Kohler; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

7.  Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.

Authors:  Sherri L Stewart; Rhea Harewood; Melissa Matz; Sun Hee Rim; Susan A Sabatino; Kevin C Ward; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

8.  Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008.

Authors:  S Jane Henley; Theodore C Larson; Manxia Wu; Vinicius C S Antao; Mary Lewis; Germania A Pinheiro; Christie Eheman
Journal:  Int J Occup Environ Health       Date:  2013 Jan-Mar

9.  How generalizable are the SEER registries to the cancer populations of the USA?

Authors:  Tzy-Mey Kuo; Lee R Mobley
Journal:  Cancer Causes Control       Date:  2016-07-21       Impact factor: 2.506

10.  Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database.

Authors:  Muhammad Umar Jawad; Sean P Scully
Journal:  J Hematol Oncol       Date:  2009-09-24       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.